๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Dose-escalation study for the treatment of Hodgkin's disease

โœ Scribed by V. Diehl

Publisher
Springer
Year
1993
Tongue
English
Weight
192 KB
Volume
66
Category
Article
ISSN
0939-5555

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Tolerability of isradipine in early Park
Tolerability of isradipine in early Parkinson's disease: A pilot dose escalation study
โœ Tanya Simuni; Emily Borushko; Michael J. Avram; Scott Miskevics; Audrey Martel; ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 958 KB

## Abstract Recent data suggests that isradipine, a dihydropyridine calcium channel blocker, is neuroprotective in preclinical models of parkinsonism. Isradipine has not been systematically studied in patients with Parkinson's disease (PD). The aim of this study was to evaluate safety and tolerabil

The treatment of advanced hodgkin's dise
The treatment of advanced hodgkin's disease
โœ Straus, D. J. ;Lee, B. J. ;Koziner, B. ;Nisce, L. Z. ;Young, C. W. ;Clarkson, B. ๐Ÿ“‚ Article ๐Ÿ“… 1981 ๐Ÿ› Springer-Verlag โš– 353 KB

Between January, 1975, and December, 1978, 118 patients with advanced Hodgkin's disease were treated with 8 months of alternating MOPP and adriamycin, bleomycin, dacarbazine and vinblastine (ABDV) combined with 1 month of low-dose radiation therapy (2,000 rad) to areas initially involved with bulky